What does CUSIP 18914F103 represent in this 13F holders report?

CUSIP 18914F103 is the security identifier for CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock used to aggregate holder disclosures.

How many institutions held CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock in Q2 2023?

140 institutional investors reported CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock for Q2 2023. Use the holders table for investor-level position and value details.

CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)

CUSIP: 18914F103

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock
Shares outstanding: 416,598,522
Total 13F shares: 96,771,026
Share change: -26,096,692
Total reported value: $86,789,528
Put/Call ratio: 63%
Price per share: $0.90
Number of holders: 140
Value change: -$22,993,945
Number of buys: 53
Number of sells: 76

Quarterly Holders Quick Answers

What is CUSIP 18914F103?
CUSIP 18914F103 identifies CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 18914F103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Chamath Palihapitiya	3/4/5	FORMER CHIEF EXECUTIVE OFFICER AND DIRECTOR, 10%+ Owner	— class O/S missing	30,147,610	$29,544,657	—	07 Jul 2021	3/4/5
VANGUARD GROUP INC	13F	Company	8%	33,161,305	$28,024,620	—	31 Mar 2023	13F
GREENOAKS CAPITAL PARTNERS LLC	3/4/5	Other*, 10%+ Owner	— class O/S missing	25,754,556	$24,466,828	—	22 Nov 2021	3/4/5
BlackRock Finance, Inc.	13F	Company	6.4%	26,603,106	$22,482,285	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	2.1%	8,813,086	$7,447,145	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.7%	6,905,301	$5,835,669	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1.6%	6,848,400	$5,788,000	—	31 Mar 2023	13F
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	1.3%	5,263,220	$4,447,422	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.79%	3,311,951	$2,798,930	—	31 Mar 2023	13F
Joseph R. Martin	3/4/5	General Counsel	— class O/S missing	2,718,857	$2,664,480	—	14 Jun 2023	3/4/5
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.57%	2,386,623	$2,016,935	—	31 Mar 2023	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.57%	2,385,745	$2,016,193	—	31 Mar 2023	13F
JUPITER ASSET MANAGEMENT LTD	13F	Company	0.57%	2,365,118	$2,001,126	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.45%	1,871,812	$1,581,868	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.38%	1,575,659	$1,331,589	—	31 Mar 2023	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.36%	1,500,000	$1,267,650	—	31 Mar 2023	13F
Nathaniel S. Turner	3/4/5	Director	— class O/S missing	1,324,728	$1,258,492	—	07 Jan 2021	3/4/5
Qube Research & Technologies Ltd	13F	Company	0.33%	1,389,916	$1,174,618	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.33%	1,379,824	$1,166,089	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.29%	1,188,083	$1,004,049	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.25%	1,041,822	$880,000	—	31 Mar 2023	13F
Prabhdeep Singh	3/4/5	Chief Growth Officer	— class O/S missing	872,821	$855,365	—	16 Sep 2022	3/4/5
Invesco Ltd.	13F	Company	0.24%	985,094	$832,503	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.23%	975,639	$824,513	—	31 Mar 2023	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.2%	828,279	$700,205	—	31 Mar 2023	13F
Swiss National Bank	13F	Company	0.17%	703,700	$594,697	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.14%	581,481	$491,351	—	31 Mar 2023	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.14%	579,191	$489,474	—	31 Mar 2023	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.13%	551,171	$465,795	—	31 Mar 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.12%	479,433	$405,000	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.11%	461,717	$390,000	—	31 Mar 2023	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.1%	430,030	$363,418	—	31 Mar 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.09%	391,646	$330,980	—	31 Mar 2023	13F
GROUP ONE TRADING LLC	13F	Company	0.09%	389,500	$329,166	—	31 Mar 2023	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.09%	386,365	$327,000	—	31 Mar 2023	13F
Cubist Systematic Strategies, LLC	13F	Company	0.09%	381,177	$322,133	—	31 Mar 2023	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.09%	375,800	$317,589	—	31 Mar 2023	13F
OSAIC HOLDINGS, INC.	13F	Company	0.07%	273,430	$231,035	—	31 Mar 2023	13F
SG Americas Securities, LLC	13F	Company	0.06%	263,953	$223,000	—	31 Mar 2023	13F
SAGE RHINO CAPITAL LLC	13F	Company	0.06%	261,500	$220,994	—	31 Mar 2023	13F
CREDIT SUISSE AG/	13F	Company	0.06%	259,017	$218,895	—	31 Mar 2023	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.06%	258,778	$218,693	—	31 Mar 2023	13F
DEUTSCHE BANK AG\	13F	Company	0.06%	249,966	$211,222	—	31 Mar 2023	13F
BARCLAYS PLC	13F	Company	0.06%	236,256	$199,660	—	31 Mar 2023	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.05%	228,252	$192,896	—	31 Mar 2023	13F
MetLife Investment Management, LLC	13F	Company	0.05%	214,239	$181,053	—	31 Mar 2023	13F
STRS OHIO	13F	Company	0.05%	198,500	$167,000	—	31 Mar 2023	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.04%	186,449	$157,568	—	31 Mar 2023	13F
Virtu Financial LLC	13F	Company	0.04%	180,665	$153,000	—	31 Mar 2023	13F
COMMONWEALTH EQUITY SERVICES, LLC	13F	Company	0.04%	180,209	$152,000	—	31 Mar 2023	13F

Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q2 2023

As of 30 Jun 2023, CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) was held by 140 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 96,771,026 shares. The largest 10 holders included VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., CITADEL ADVISORS LLC, PNC Financial Services Group, Inc., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, JUPITER ASSET MANAGEMENT LTD, and Cubist Systematic Strategies, LLC. This page lists 142 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

150

Q2 2023 holders

140

Holder diff

-10

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.